Joshua Pearson, James B Badenoch, Daniel Van Wamelen
{"title":"Using prodromal non-motor symptoms to predict Parkinson's disease onset and motor phenotype.","authors":"Joshua Pearson, James B Badenoch, Daniel Van Wamelen","doi":"10.1136/jnnp-2024-335429","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Non-motor symptoms are highly prevalent in prodromal Parkinson's disease (PD); however, their impact on PD trajectory remains largely unexplored. We aimed to assess whether prevalent prodromal non-motor symptoms could predict future motor phenotype and time-to-PD diagnosis.</p><p><strong>Methods: </strong>We studied the prodromal cohort of the ongoing Parkinson's Progression Markers Initiative (n=958), which prospectively assesses individuals with prodromal PD features (genetic: n=361, hyposmia: n=298, rapid eye movement behaviour disorder: n=136, combination: n=163) with up to 10 years of follow-up. The presence of prevalent prodromal symptoms was defined by evidence-based cut-off scores. In unmedicated or OFF-state PD converters (total n=52), binary logistic regression models established whether these predicted non-tremor-dominant (n=35) and tremor-dominant (n=17) motor phenotypes at diagnosis. Cox proportional hazards models determined whether identified prodromal symptoms predicted a shorter time-to-phenoconversion across all PD converters (n=59) and non-converters (n=343). Both models adjusted for age and sex.</p><p><strong>Results: </strong>Prodromal anxiety and hyposmia were each associated with an increased risk of subsequent non-tremor-dominant PD, compared with other motor phenotypes (adjusted OR=4.45, 95% CI 1.34 to 15.27 and adjusted OR=3.90, 95% CI 1.01 to 15.16, respectively). Concurrent prodromal anxiety and hyposmia predicted an increased risk of PD phenoconversion over time (HR=4.93, 95% CI 2.71 to 8.98).</p><p><strong>Conclusion: </strong>In this exploratory analysis, individuals with prodromal hyposmia and anxiety phenoconverted to PD sooner and more often had a non-tremor-dominant phenotype, potentially reflecting more widespread pathology or specific pathophysiology underlying these symptoms. This may improve phenotyping prodromal PD and stratifying poorer prognostic trajectories for earlier and more personalised management.</p>","PeriodicalId":16418,"journal":{"name":"Journal of Neurology, Neurosurgery, and Psychiatry","volume":" ","pages":""},"PeriodicalIF":8.7000,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neurology, Neurosurgery, and Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/jnnp-2024-335429","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Non-motor symptoms are highly prevalent in prodromal Parkinson's disease (PD); however, their impact on PD trajectory remains largely unexplored. We aimed to assess whether prevalent prodromal non-motor symptoms could predict future motor phenotype and time-to-PD diagnosis.
Methods: We studied the prodromal cohort of the ongoing Parkinson's Progression Markers Initiative (n=958), which prospectively assesses individuals with prodromal PD features (genetic: n=361, hyposmia: n=298, rapid eye movement behaviour disorder: n=136, combination: n=163) with up to 10 years of follow-up. The presence of prevalent prodromal symptoms was defined by evidence-based cut-off scores. In unmedicated or OFF-state PD converters (total n=52), binary logistic regression models established whether these predicted non-tremor-dominant (n=35) and tremor-dominant (n=17) motor phenotypes at diagnosis. Cox proportional hazards models determined whether identified prodromal symptoms predicted a shorter time-to-phenoconversion across all PD converters (n=59) and non-converters (n=343). Both models adjusted for age and sex.
Results: Prodromal anxiety and hyposmia were each associated with an increased risk of subsequent non-tremor-dominant PD, compared with other motor phenotypes (adjusted OR=4.45, 95% CI 1.34 to 15.27 and adjusted OR=3.90, 95% CI 1.01 to 15.16, respectively). Concurrent prodromal anxiety and hyposmia predicted an increased risk of PD phenoconversion over time (HR=4.93, 95% CI 2.71 to 8.98).
Conclusion: In this exploratory analysis, individuals with prodromal hyposmia and anxiety phenoconverted to PD sooner and more often had a non-tremor-dominant phenotype, potentially reflecting more widespread pathology or specific pathophysiology underlying these symptoms. This may improve phenotyping prodromal PD and stratifying poorer prognostic trajectories for earlier and more personalised management.
背景:非运动症状在前驱帕金森病(PD)中非常普遍;然而,它们对PD轨迹的影响在很大程度上仍未被探索。我们的目的是评估普遍的前驱非运动症状是否可以预测未来的运动表型和pd诊断时间。方法:我们研究了正在进行的帕金森进展标志物计划的前驱队列(n=958),该队列前瞻性地评估了具有PD前驱特征的个体(遗传:n=361,低血症:n=298,快速眼动行为障碍:n=136,组合:n=163),随访时间长达10年。普遍前驱症状的存在通过循证截止评分来定义。在未用药或关闭状态的PD转换器(总n=52)中,二元逻辑回归模型建立了这些模型在诊断时是否预测非震颤显性(n=35)和震颤显性(n=17)的运动表型。Cox比例风险模型确定了在所有PD转换者(n=59)和非PD转换者(n=343)中,确定的前驱症状是否预测了较短的到表型转换时间。两个模型都根据年龄和性别进行了调整。结果:与其他运动表型相比,前驱焦虑和低血症均与随后非震颤显性PD的风险增加相关(调整后的OR=4.45, 95% CI 1.34至15.27,调整后的OR=3.90, 95% CI 1.01至15.16)。伴发的前驱焦虑和低血症预示着PD表型转化的风险随时间增加(HR=4.93, 95% CI 2.71 - 8.98)。结论:在这项探索性分析中,前驱低血症和焦虑症状转化为PD的个体更早且更经常具有非震颤显性表型,可能反映了这些症状背后更广泛的病理或特定的病理生理。这可能会改善PD前驱的表型,并对较差的预后轨迹进行分层,以便更早和更个性化的治疗。
期刊介绍:
The Journal of Neurology, Neurosurgery & Psychiatry (JNNP) aspires to publish groundbreaking and cutting-edge research worldwide. Covering the entire spectrum of neurological sciences, the journal focuses on common disorders like stroke, multiple sclerosis, Parkinson’s disease, epilepsy, peripheral neuropathy, subarachnoid haemorrhage, and neuropsychiatry, while also addressing complex challenges such as ALS. With early online publication, regular podcasts, and an extensive archive collection boasting the longest half-life in clinical neuroscience journals, JNNP aims to be a trailblazer in the field.